NETE Financial Statements & Analysis
Complete financial statements for NETE including income statement, balance sheet, and cash flow statement. Analyze NETE's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).
Financial Health Score
Financial Health Score
Income Statement
Revenue
-123.6% ↓
Net Income
-0.1% ↓
Gross Margin
524.4% ↑
Operating Margin
523.5% ↑
Balance Sheet
Current Ratio
-10.2% ↓
Debt to Equity
3.2% ↓
Asset Turnover
-139.8% ↓
Cash Flow
Operating Cash Flow
-29.9% ↓
Net Cash Flow
-0.0% ↓
Free Cash Flow
-24.3% ↓
Cash Flow to Debt
9.2% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | TTM Q1 '25 | TTM Q2 '25 | Change | Impact |
|---|---|---|---|---|
| Revenue | 33.29M | -7.87M | 123.6% | |
| Gross Profit | -6.59B | -6.61B | 0.3% | |
| Operating Income | -51.52B | -51.58B | 0.1% | |
| Net Income | -115.00B | -115.14B | 0.1% | |
| EPS | -618.99 | -640.26 | 3.4% | |
| EBITDA | -100.20B | -100.22B | 0.0% | |
| Gross Margin | -19801.25% | 84038.64% | 524.4% | |
| Operating Margin | -154760.67% | 655368.60% | 523.5% | |
| Net Income Margin | -345439.11% | 1462862.16% | 523.5% | |
| R&D Expenses | 11.30B | 11.31B | 0.1% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | TTM Q3 '21 | TTM Q2 '21 |
|---|---|---|---|---|---|
| Revenue | -7.87M | 33.29M | 57.08M | — | — |
| Gross Profit | -6.61B | -6.59B | -6.58B | — | — |
| Operating Income | -51.58B | -51.52B | -51.46B | — | — |
| Net Income | -115.14B | -115.00B | -114.96B | — | — |
| EPS | -640.26 | -618.99 | -599.78 | — | — |
| EBITDA | -100.22B | -100.20B | -100.18B | — | — |
| Gross Margin | 84038.64% | -19801.25% | -11532.13% | — | — |
| Operating Margin | 655368.60% | -154760.67% | -90152.67% | — | — |
| Net Income Margin | 1462862.16% | -345439.11% | -201404.05% | — | — |
| R&D Expenses | 11.31B | 11.30B | 11.29B | — | — |
Financial Metrics
Want to dive deeper into NETE's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics